Pralatrexate

http://dbpedia.org/resource/Pralatrexate an entity of type: Thing

Pralatrexate, sold under the brand name Folotyn, is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Pralatrexate was approved for medical use in the United States in September 2009, as the first treatment for Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma. rdf:langString
rdf:langString Pralatrexate
xsd:integer 1300596
xsd:integer 1123038028
rdf:langString BA05
rdf:langString L01
xsd:integer 23
xsd:integer 146464
xsd:integer 71223
xsd:integer 1201746
xsd:integer 130578
rdf:langString DB06813
xsd:integer 23
rdf:langString Pralatrexate ball-and-stick.png
rdf:langString N--(L)-glutamic acid
rdf:langString D05589
rdf:langString Rx-only
xsd:integer 7
xsd:integer 5
xsd:integer 148121
rdf:langString O=C[C@@H]CCCO
xsd:integer 1
rdf:langString OGSBUKJUDHAQEA-WMCAAGNKSA-N
rdf:langString Folotyn
rdf:langString A8Q8I19Q20
rdf:langString changed
xsd:integer 461750802
xsd:integer 300
rdf:langString Pralatrexate, sold under the brand name Folotyn, is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Pralatrexate was approved for medical use in the United States in September 2009, as the first treatment for Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.
xsd:integer 6840
rdf:langString Rx-only
rdf:langString Pralatrexate
xsd:nonNegativeInteger 8727
rdf:langString Folotyn
xsd:string 146464-95-1
xsd:string 71223
xsd:string 1201746
xsd:string DB06813
xsd:string A8Q8I19Q20
xsd:string D05589
xsd:string 148121

data from the linked data cloud